The clinical response rates were higher compared to placebo but failed to reach statistical significance [ 26 ].
← all excerpts
Use of Rituximab in Management of Rapidly Progressive Glomerulonephritis.
1
—
—
The clinical response rates were higher compared to placebo but failed to reach statistical significance [ 26 ].